Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation

American Journal of Cardiology

Volumn 113, Issue 4, 2014, Pages 662-668

  Qureshi, Waqas ^a   Mittal, Chetan ^b   Patsias, Iani ^b   Garikapati, Kiran ^b   Kuchipudi, Aishwarya ^b   Cheema, Gagandeep ^b   Elbatta, Mohammad ^b   Alirhayim, Zaid ^b   Khalid, Fatima ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; WARFARIN;

EID: 84895069540     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.10.044     Document Type: Article

References (19)

1. J.W. Mant Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation Thromb Haemost 100 2008 14 15
2. T. Suehiro, Y. Yakeishi, F. Sakai, K. Matsuzaki, K. Sanefuji, T. Toyokawa, K. Shioshita, Y. Sugie, Y. Okudaira, T. Kano, H. Mine, K. Suetsugu, F. Suetsugu, N. Suehiro, and K. Suhiro Gastrointestinal bleeding and blood transfusion in the elderly in Japan Hepatogastroenterology 59 2012 1480 1483
3. J.K. Lee, H.W. Kang, S.G. Kim, J.S. Kim, and H.C. Jung Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy Int J Clin Pract 66 2012 64 68
4. S.D. Fihn, M. McDonell, D. Martin, J. Henikoff, D. Vermes, D. Kent, and R.H. White Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group Ann Intern Med 118 1993 511 520
5. C.S. Landefeld, and R.J. Beyth Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention Am J Med 95 1993 315 328
6. J. Raunso, C. Selmer, J.B. Olesen, M.G. Charlot, A.M. Olsen, D.M. Bretler, J.D. Nielsen, H. Dominguez, N. Gadsboll, L. Kober, G.H. Gislason, C. Torp-Pedersen, and M.L. Hansen Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation Eur Heart J 33 2012 1886 1892
7. P. Smith Long-term anticoagulant treatment after acute myocardial infarction. The Warfarin Re-Infarction Study Ann Epidemiol 2 1992 549 552
8. A.K. Das, P.D. Willcoxson, O.J. Corrado, and R.M. West The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation Age Ageing 36 2007 95 97
9. D.G. Sherman, S.G. Kim, B.S. Boop, S.D. Corley, J.P. Dimarco, R.G. Hart, L.J. Haywood, K. Hoyte, E.S. Kaufman, M.H. Kim, E. Nasco, and A.L. Waldo Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191
10. D.A. Garcia, S. Regan, L.E. Henault, A. Upadhyay, J. Baker, M. Othman, and E.M. Hylek Risk of thromboembolism with short-term interruption of warfarin therapy Arch Intern Med 168 2008 63 69
11. E. Jamula, N.S. Lloyd, J.D. Schwalm, K.E. Airaksinen, and J.D. Douketis Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis Chest 138 2010 840 847
12. H. Ghanbari, D. Feldman, M. Schmidt, J. Ottino, C. Machado, N. Akoum, T.S. Wall, and M. Daccarett Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios Pacing Clin Electrophysiol 33 2010 400 406
13. C. Tompkins, A. Cheng, D. Dalal, J.A. Brinker, C.T. Leng, J.E. Marine, S. Nazarian, D.D. Spragg, S. Sinha, H. Halperin, G.F. Tomaselli, R.D. Berger, H. Calkins, and C.A. Henrikson Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 2010 2376 2382
14. A.K. Jaffer, D.J. Brotman, L.D. Bash, S.K. Mahmood, B. Lott, and R.H. White Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals Am J Med 123 2010 141 150
15. L. Michaels, and R.E. Beamish Relapses of thromboembolic disease after discontinued anticoagulant therapy. A comparison of the incidence after abrupt and after gradual termination of treatment Am J Cardiol 20 1967 670 673
16. J. Harenberg, R. Haas, and R. Zimmermann Plasma hypercoagulability after termination of oral anticoagulants Thromb Res 29 1983 627 633
17. U. Genewein, A. Haeberli, P.W. Straub, and J.H. Beer Rebound after cessation of oral anticoagulant therapy: the biochemical evidence Br J Haematol 92 1996 479 485
18. G. Palareti, and C. Legnani Warfarin withdrawal. Pharmacokinetic- pharmacodynamic considerations Clin Pharmacokinet 30 1996 300 313
19. M.B. Rothberg, C. Celestin, L.D. Fiore, E. Lawler, and J.R. Cook Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit Ann Intern Med 143 2005 241 250